Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
常规交易时段
US$18.465
+US$0.215 · +1.18%
盘中时间采用ET。市场数据可能有所延迟。
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
日内区间
当前US$18.465
52周区间
当前US$18.465
盘中时间采用ET。市场数据可能有所延迟。
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
日内区间
当前US$18.465
52周区间
当前US$18.465
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 22.48亿 USD | 21.08亿 USD | 17.07亿 USD | 15.63亿 USD | 14.26亿 USD |
| 销货成本 | 9.03亿 USD | 9.27亿 USD | 7.16亿 USD | 6.94亿 USD | 6.49亿 USD |
| 毛利 | 13.45亿 USD | 11.81亿 USD | 9.91亿 USD | 8.69亿 USD | 7.78亿 USD |
| 研究与开发 | 1.2亿 USD | 9129.8万 USD | 7533.1万 USD | 6082.7万 USD | 4909.4万 USD |
| 销售、一般及管理费用 | 10.7亿 USD | 9.39亿 USD | 8.3亿 USD | 7.73亿 USD | 6.66亿 USD |
| 营业费用 | 13.64亿 USD | 19.56亿 USD | 10.56亿 USD | 9.41亿 USD | 8.4亿 USD |
| 利息收入 | — | — | — | 20万 USD | — |
| 利息支出 | 3482.3万 USD | 5710万 USD | 1974.9万 USD | 2495.2万 USD | 2911.2万 USD |
| 折旧和摊销 | 2.94亿 USD | 2.85亿 USD | 2.17亿 USD | 2.2亿 USD | 2.63亿 USD |
| 营业利润 | −1886.9万 USD | −7.76亿 USD | −6570.9万 USD | −7117.8万 USD | −6279.9万 USD |
| 净利润 | −11.84亿 USD | −8.25亿 USD | −3326.1万 USD | −1329.2万 USD | 7165.7万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$36.33
上涨空间 96.75%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2022年4月5日 | 1:3 | — | — |
已生效 2022年4月5日
1:3
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI4276.84万0.00%2.3万亿 USD0.03%US$380.86-0.19%
Avantis U.S. Small Cap Value ETFAVUV4041.41万0.13%309.17亿 USD0.25%US$120.01+0.06%
Vanguard Morningstar Small-Cap ETFVB3091.59万0.02%1853亿 USD0.03%US$286.92-0.43%
iShares Russell 2000 ETFIWM2699.39万0.04%787.4亿 USD0.19%US$276.23-0.60%
Vanguard Morningstar Small-Cap Value ETFVBR1964.89万0.03%682亿 USD0.05%US$234.47-0.10%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1661.43万0.06%268.33亿 USD0.33%US$38.015+0.09%
Vanguard Extended Market ETFVXF1644.49万0.02%954亿 USD0.05%US$231.89-0.70%
iShares Russell 2000 Value ETFIWN982.55万0.07%137.49亿 USD0.24%US$210.39-0.33%
Vanguard Morningstar Total Stock Market ETFVTI
Avantis U.S. Small Cap Value ETFAVUV
Vanguard Morningstar Small-Cap ETFVB
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap Value ETFVBR
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
iShares Russell 2000 Value ETFIWNAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。